Sanbo Hospital Management Group Ltd. A (301293) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Sanbo Hospital Management Group Ltd. A ¥8.99, price ¥48.85, upside -81.6%, quality 39 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Sanbo Hospital Management Group Ltd. A for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
41‑month range ¥30.01 – ¥98.88 · fair‑value band ¥7.08 – ¥11.24 · the ¥48.85 price screens above the ¥8.99 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Sanbo Hospital Management Group Ltd. A in your weekly email
Every Wednesday you see whether Sanbo Hospital Management Group Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Sanbo Hospital Management Group Limited, together with its subsidiaries, engages in hospital management in China. The company operates neurology and general hospitals. It is also involved in clinical medical; medical device management; medical investment; and property management services.
Show more
Sanbo Hospital Management Group Limited, together with its subsidiaries, engages in hospital management in China. The company operates neurology and general hospitals. It is also involved in clinical medical; medical device management; medical investment; and property management services. Sanbo Hospital Management Group Limited was founded in 2003 and is headquartered in Beijing, China.
Stock analysis
Sanbo Hospital Management Group Ltd. A (301293) currently trades at ¥48.85, while our model-based Fair Value estimate is ¥8.99, 81.6% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥10.12 per share, and 0 of the 14 models we run sit above the ¥48.85 price.
Bear case: the Economic Profit group reads lowest at ¥5.32, and 14 of the 14 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥7.08 (bear) to ¥11.24 (bull), the price of ¥48.85 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Sanbo Hospital Management Group Ltd. A reported revenue of 1.7B CNY in FY2025 versus 1.1B CNY in FY2021, a compound +11.0%/yr. Reported net income was 84.2M CNY in FY2025, compounding +2.4%/yr from FY2021.
Key figures
Market cap 11.2B CNY (≈ $1.7B) · P/E ratio 168.4 · P/S ratio 8.22 · EPS (TTM) ¥0.2900 · Net margin 4.9% · Return on equity 1.6% · Return on assets (EBIT) 4.8% · Operating margin 6.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 51% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −82%, 301293 screens richer than that median.
Fair Value models
Bear ¥7.08Fair Value ¥8.99Bull ¥11.24
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.2193 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+20.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.3%
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−3.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.8%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 9%
Compare Sanbo Hospital Management Group Ltd. A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 241 stocks
Beats the industry median on 2/13 measures
Overall it trails its industry peers.
Valuation
Quality Score39 · Bottom 25%
Fair Value upside−81.6% · Bottom 25%
Profitability
Return on equity (TTM)1.6% · Below median
Return on assets1.9% · Below median
Net margin (TTM)3.4% · Below median
Operating margin (TTM)6.3% · Below median
Growth and dividend
Revenue growth13.1% · Above median
Dividend yield (TTM)0.0% · Bottom 25%
Balance sheet
Debt / equity0.18× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (TTM)168.4× · Priciest 25%
P/B4.76× · Priciest 25%
P/S (TTM)6.28× · Priciest 25%
EV/EBITDA54.5× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)66· sector 29
PAST (return on equity)6· sector 32
HEALTH (low debt)91· sector 89
DIVIDEND (yield)0· sector 38
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Sanbo Hospital Management Group Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/301293
Frequently asked questions
Is Sanbo Hospital Management Group Ltd. A (301293) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥8.99 versus a price of ¥48.85, about −82% upside (overvalued).
What is the fair value of 301293?
Our model-based fair value for Sanbo Hospital Management Group Ltd. A is ¥8.99 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥48.85.
What is the quality score of 301293?
Sanbo Hospital Management Group Ltd. A has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sanbo Hospital Management Group Ltd. A (301293)?
Our model-based price target is the fair value of ¥8.99 (as of Sep 24, 2026) from 14 valuation models. Cautious scenario ¥7.08, optimistic scenario ¥11.24. It is a calculation from audited fundamentals, not an analyst target.
What is the Sanbo Hospital Management Group Ltd. A stock forecast for 2026?
Our models put fair value at ¥8.99, about −82% upside versus a price of ¥48.85 (overvalued). Cautious scenario ¥7.08, optimistic scenario ¥11.24. The calculation is refreshed regularly with new filings.
What is the revenue of Sanbo Hospital Management Group Ltd. A (301293)?
Sanbo Hospital Management Group Ltd. A reported trailing-twelve-month revenue of about 1.8B CNY (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Sanbo Hospital Management Group Ltd. A (301293)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sanbo Hospital Management Group Ltd. A it is ¥8.99 per share (as of Sep 24, 2026), against a price of ¥48.85. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Sanbo Hospital Management Group Ltd. A stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 301293 trades above its calculated fair value: price ¥48.85, fair value ¥8.99, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301293?
No. The price is what the market pays today (¥48.85); the fair value is what the company's own numbers justify (¥8.99). For Sanbo Hospital Management Group Ltd. A the two are ¥39.86 per share apart. That gap is exactly why we show both numbers side by side.
How much is Sanbo Hospital Management Group Ltd. A worth?
The market values Sanbo Hospital Management Group Ltd. A at about 11.2B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥48.85; our models calculate a fair value of ¥8.99 per share.
What do the bullish and bearish scenarios say about 301293?
Our models span a range for Sanbo Hospital Management Group Ltd. A: cautious scenario ¥7.08, base ¥8.99, optimistic ¥11.24 per share (as of Sep 24, 2026, price ¥48.85). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 301293?
Sanbo Hospital Management Group Ltd. A trades at a price-to-earnings ratio of 168.4 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥8.99 is built from several models across several years. Other multiples: P/B 4.8, P/S 6.3, EV/EBITDA 54.5.
How solid is the balance sheet of Sanbo Hospital Management Group Ltd. A (301293)?
Balance-sheet figures for Sanbo Hospital Management Group Ltd. A (as of Sep 24, 2026): return on equity 1.6%, debt of 0.18 per unit of equity. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is 301293 from its 52-week high?
Sanbo Hospital Management Group Ltd. A trades at ¥48.85, about 51% below its 52-week high of ¥98.88 and 2% above the low of ¥47.70 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of ¥8.99 is for.
Which stocks are comparable to Sanbo Hospital Management Group Ltd. A?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sanbo Hospital Management Group Ltd. A stock attractive at the current price?
The data as of Sep 24, 2026: price ¥48.85, calculated fair value ¥8.99 (−82%), Quality Score 39/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301293 calculated?
We run Sanbo Hospital Management Group Ltd. A through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥8.99, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Sanbo Hospital Management Group Ltd. A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sanbo Hospital Management Group Ltd. A (301293)?
The closing price on Sep 30, 2026 was ¥48.85. Our model-based fair value is ¥8.99, about −82% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sanbo Hospital Management Group Ltd. A right now?
The price sits above even our optimistic bull case (¥11.24). The favourable scenario is already priced in. Weak quality (39/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Sanbo Hospital Management Group Ltd. A
How large is the market capitalisation of Sanbo Hospital Management Group Ltd. A (301293)?
The market capitalisation of Sanbo Hospital Management Group Ltd. A is 11.2B CNY (≈ $1.7B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sanbo Hospital Management Group Ltd. A (301293)?
The price-to-sales ratio of Sanbo Hospital Management Group Ltd. A is 8.22 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sanbo Hospital Management Group Ltd. A (301293)?
Earnings per share at Sanbo Hospital Management Group Ltd. A are ¥0.2900 (price ÷ EPS = P/E 168.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Sanbo Hospital Management Group Ltd. A (301293)?
The net margin of Sanbo Hospital Management Group Ltd. A is 4.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sanbo Hospital Management Group Ltd. A (301293)?
The return on equity (ROE) of Sanbo Hospital Management Group Ltd. A is 1.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sanbo Hospital Management Group Ltd. A (301293)?
On an EBIT basis the return on assets of Sanbo Hospital Management Group Ltd. A is 4.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sanbo Hospital Management Group Ltd. A (301293)?
The operating margin of Sanbo Hospital Management Group Ltd. A is 6.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sanbo Hospital Management Group Ltd. A (301293)?
Revenue at Sanbo Hospital Management Group Ltd. A is growing +13.1% versus a year earlier (3y avg +17.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sanbo Hospital Management Group Ltd. A (301293)?
Earnings per share at Sanbo Hospital Management Group Ltd. A are growing −63.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Sanbo Hospital Management Group Ltd. A (301293) generate?
The free cash flow of Sanbo Hospital Management Group Ltd. A is −398M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Sanbo Hospital Management Group Ltd. A in the live analysis
One click puts Sanbo Hospital Management Group Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
